However, advancements are extending its utility far beyond imaging, offering innovative functionalities that support and ...

The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...

Bayer today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane for contrast-enhanced magnetic ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...

Berlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...

The oft-injured infielder has a strained left hamstring, the same one that caused him to miss 35 games this season ...

AiMIFY™ leverages advanced AI technology to amplify the contrast enhancement of brain MRI scans — up to twice the level ...

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.

For the study, investigators will use EEG to monitor brain activity in dogs with epilepsy and compare the frequency and type ...

Cape Fear Community College announces the launch of two new certificate programs, Computed Tomography and Magnetic Resonance ...